Marksans Pharma Limited

MARKSANSNSE · IN

Holders

Groww Mutual Fund (scheme IB18)
0.0% of their portfolio
₹10.39 L
3,809 sh
as-of 30 Jun 2026Monthly
Groww Mutual Fund (scheme NI)
0.0% of their portfolio
₹9.85 L
3,812 sh
as-of 31 Jul 2026T+30

Ownership

FIIs raised their stake +0.7pp QoQ

Jun 2026 quarter

Upgrade to see this quarter’s exact figures

Ownership by quarter

Promoter

— 0.0pp

Disclosure timeline

REDUCEDT+30
Microcurves Trading Private Limited
Marksans Pharma Limited · NSE
−43,49,697 sh · ₹136.32 Cr
Filed 12 Aug 2026NSE bulk dealview source
ACQUIREDT+30
Microcurves Trading Private Limited
Marksans Pharma Limited · NSE
+43,49,697 sh · ₹136.25 Cr
Filed 12 Aug 2026NSE bulk dealview source
DISCLOSEDT+30
Groww Mutual Fund (scheme NI)
Marksans Pharma Limited · NSE
3,812 sh · ₹9.85 L
Filed 31 Jul 2026AMFI portfolioview source
DISCLOSEDMonthly
Groww Mutual Fund (scheme IB18)
Marksans Pharma Limited · NSE
3,809 sh · ₹10.39 L
Filed 30 Jun 2026AMFI portfolioview source
DISCLOSEDStale
Groww Mutual Fund (scheme NI)
Marksans Pharma Limited · NSE
4,473 sh · ₹11.01 L
Filed 31 May 2026AMFI portfolioview source

Announcements

The announcements library is part of Pro.

Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.

25 announcements on record for this company.

Part of Pro — upgrade to open